Home/ Supplements/ Alpha Lipoic Acid/ Resistance C Raspberry Flavored Drink Mi...

Resistance C Raspberry Flavored Drink Mix

product on market Powder Resistance C Safety: 99/100
99/100

This product looks safe

  • Vitamin B9: 16.7mg is 16.7× the Tolerable Upper Intake Level (1.0mg)
  • 43% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The listed ingredients consist of basic macronutrients, including proteins and carbohydrates, which provide foundational energy and structural support for the body. There is strong evidence supporting the role of these nutrients in maintaining general physiological function. The product maintains a high safety score, indicating no significant concerns regarding its primary components.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Vitamin B9: 16.7mg is 16.7× the Tolerable Upper Intake Level (1.0mg)

Label

Product Label

Label for Resistance C Raspberry Flavored Drink Mix
Open Full PDF View on NIH DSLD →
Details

Label Data

8 Gram(s)
Serving Size
14
Servings
Other Combinations
Product Type
43%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
20 Calorie(s)
Total Fat
Cholesterol
Total Carbohydrates
5 Gram(s) (2% DV)
Protein
Vitamin A
3635 mcg RAE (404% DV)
Vitamin C
1000 mg (1111% DV)
380 mcg (32% DV)
Within RDA (0.3× RDA) 76 studies (A:0, B:33)
430 mcg (33% DV)
Within RDA (0.3× RDA) 13 studies (A:0, B:1)
20 mg NE (125% DV)
1.4× RDA — within safe limits 196 studies (A:5, B:63)
10 mg (588% DV)
7.7× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
16.7 mcg DFE (4% DV)
Exceeds UL by 16.7× (UL: 1.0 mg) 226 studies (A:10, B:105)
30 mcg (1250% DV)
12.5× RDA — above typical dose 139 studies (A:1, B:44)
3 mg (60% DV)
Within RDA (0.6× RDA) 2 studies — no high-quality reviews
Calcium
50 mg (4% DV)
20 mg (5% DV)
Market median: 500.0mg (1 products) 316 studies (A:8, B:159)
30 mg (273% DV)
2.7× RDA — within safe limits 263 studies (A:6, B:134)
2 mg (87% DV)
Within RDA (0.9× RDA) 9 studies — no high-quality reviews
100 mcg (286% DV)
2.9× RDA — within safe limits 199 studies (A:1, B:55)
Potassium
25 mg (1% DV)
Market median: 200.0mg (198 products) 6 studies — no high-quality reviews

Other Ingredients

Maltodextrin Natural Flavors Citric Acid Malic Acid Stevia Silica Beta-Carotene
Claims

Label Claims — Verification

Unverified Nutrient
Info

Product Information

Warnings & Precautions

Produced in a facility that uses milk, soy, peanut, tree nut, wheat, egg, fish and shellfish ingredients.

Formulation Notes

Buffered formula

1000 mg Vitamin C 16 nutrients & 7 B vitamins Antioxidants & electrolytes

Additional Information

New

Metadata

Product Details

DSLD Entry Date2020-08-23
Product TypeOther Combinations
FormPowder
DSLD ID232167
Data Updated2026-04-11
Research

Research Evidence

21
Research Sources
52
Avg Quality
13
Rct
4
Meta Analysis
2
Systematic Review
2
Clinical Trial
A Alpha-lipoic acid for diabetic peripheral neuropathy
Systematic Review The Cochrane database of systematic reviews 2024 PubMed DOI
B Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy
Rct Nutrients 2024 PubMed DOI
B Alpha Lipoic Acid Supplementation and Iron Homeostasis: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Meta Analysis International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition 2024 PubMed DOI
B Effectiveness of alpha-lipoic acid in patients with neuropathic pain associated with type I and type II diabetes mellitus: A systematic review and meta-analysis
Meta Analysis Medicine 2023 PubMed DOI
C The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Metabolism: clinical and experimental 2018 PubMed DOI
C A systematic review and meta-analysis of α-lipoic acid in the treatment of diabetic peripheral neuropathy
Meta Analysis European journal of endocrinology 2012 PubMed DOI
C Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study
Rct Endocrine, metabolic & immune disorders drug targets 2020 PubMed DOI
C A randomized, double-blind, placebo controlled study to evaluate the effect of alpha-lipoic acid on inhibition of ADP-and collagen-induced platelet aggregation ex vivo in diabetic neuropathy patients on gabapentin or pregabalin
Rct Journal of postgraduate medicine 2024 PubMed DOI
C Ranking Alpha Lipoic Acid and Gamma Linolenic Acid in Terms of Efficacy and Safety in the Management of Adults With Diabetic Peripheral Neuropathy: A Systematic Review and Network Meta-analysis
Systematic Review Canadian journal of diabetes 2024 PubMed DOI
C Effect analysis of tanshinone IIA sulfonate sodium combined with a-lipoic acid in patients with diabetes peripheral neuropathy.
Rct Pakistan journal of pharmaceutical sciences PubMed
View all evidence for Alpha Lipoic Acid →
Compare

Similar Products

View all Alpha Lipoic Acid products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.